Schröter M, Feucht H H, Schäfer P, Zöllner B, Laufs R
Institut für Medizinische Mikrobiologie und Immunologie, Universitäts-Krankenhaus Eppendorf, 20246 Hamburg, Germany.
J Clin Microbiol. 1999 Aug;37(8):2576-80. doi: 10.1128/JCM.37.8.2576-2580.1999.
Serological determination of hepatitis C virus (HCV) subtypes has been hampered by the lack of suitable assays. Therefore, a recombinant immunoblot assay has been established for serological differentiation of HCV subtypes 1a, 1b, 2a, 2b, 3a, and 4a. It consists of recombinant HCV proteins from the NS-4 region propagated in Escherichia coli. To confirm the serotyping assay results, the results were compared with those obtained by nucleotide sequencing of the NS-5 region. Sera from 157 patients with chronic HCV infection were examined by this assay, and specific antibodies could be detected in 86% (n = 135) of them. The HCV genotype was determined correctly in all but one sample, and the subtypes determined by the serotyping assay corresponded to the HCV subtypes detected by nucleotide sequencing for 95% (n = 128) of the samples. These data indicate that HCV subtypes can be distinguished serologically. The assay that is described provides an easier means of identification of infection with different HCV subtypes for wider clinical and epidemiological applications.
由于缺乏合适的检测方法,丙型肝炎病毒(HCV)亚型的血清学测定受到了阻碍。因此,已建立一种重组免疫印迹检测法,用于对HCV 1a、1b、2a、2b、3a和4a亚型进行血清学分型。该检测法由在大肠杆菌中繁殖的来自NS-4区域的重组HCV蛋白组成。为了确认血清学分型检测结果,将这些结果与通过NS-5区域核苷酸测序获得的结果进行了比较。用该检测法检测了157例慢性HCV感染患者的血清,其中86%(n = 135)的患者可检测到特异性抗体。除一个样本外,所有样本的HCV基因型均被正确确定,血清学分型检测确定的亚型与95%(n = 128)的样本通过核苷酸测序检测到的HCV亚型相符。这些数据表明,HCV亚型可以通过血清学方法进行区分。所描述的检测法为更广泛的临床和流行病学应用提供了一种更简便的鉴定不同HCV亚型感染的方法。